Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.1 USD | -0.20% | -1.67% | -2.73% |
Apr. 22 | Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating | MT |
Apr. 19 | UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.73% | 186B | |
-2.20% | 107B | |
-4.08% | 67.57B | |
+5.99% | 50.7B | |
+15.32% | 47.2B | |
-0.45% | 39.72B | |
+6.60% | 27.48B | |
-1.11% | 25.65B | |
-0.76% | 24.82B | |
+13.37% | 24.97B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Evercore ISI Adjusts Price Target on Abbott Laboratories to $114 From $112, Maintains Outperform Rating